NDC product
Bayer Rapid Relief
NDC 0280-0103 · Bayer HealthCare LLC.
Key facts
| Product NDC | 0280-0103 |
|---|---|
| Proprietary name | Bayer Rapid Relief |
| Nonproprietary name | Aspirin/Caffeine Oral Powder |
| Substances | CAFFEINE, ASPIRIN |
| Dosage form | POWDER |
| Route | ORAL |
| Labeler | Bayer HealthCare LLC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M013 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE] and 5 more |
| Marketing start | Jan 13, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: